Home » New EU Unitary Patent System Could Lead to More Settlements
New EU Unitary Patent System Could Lead to More Settlements
January 10, 2013
A new unitary patent system that will allow pharmaceutical inventors to cut their costs by purchasing one patent for market entry into the 25 participating EU member states could result in more out-of-court settlements because of its all-or-nothing nature, industry experts say.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor